Molecule Details
| InChIKey | BHKKSKOHRFHHIN-MRVPVSSYSA-N |
|---|---|
| Canonical SMILES | C[C@@H](N)c1cc(Cl)ccc1Cn1c(=S)[nH]c(=O)c2[nH]ccc21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.1 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB18963 |
|---|---|
| Drug Name | Mitiperstat |
| CAS Number | 1933460-19-5 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Mitiperstat is under investigation in clinical trial NCT05492877 (An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.). |
Cross-references: BindingDB: 312172 CHEMBL5095218 ChemSpider: 114711423 Wikipedia: Mitiperstat
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P05164 | MPO | Myeloperoxidase | inhibitor | targets |